Form 4: Jaguar Health Executive Steven R. King Acquires Shares and Options

Steven R. King, a Jaguar Health executive, reports the acquisition of common stock and stock options, according to a Form 4 filing.

Summary

• Steven R. King, Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary at Jaguar Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On October 8, 2024, King acquired 4,922 shares of common stock and 39,376 stock options.
• The stock options have an exercise price of $1.29 and expire on October 8, 2034.
• The options vest ratably on a monthly basis over 36 months from the grant date, contingent upon continued employment.
• The restricted stock units vest in three equal annual installments beginning on October 8, 2025.
• The filing also notes a 60-for-1 reverse stock split that occurred on May 23, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. The executive's acquisition of shares and options could be seen as a slightly positive signal.

Positives

• The acquisition of shares and options by an executive could be interpreted as a sign of confidence in the company's future.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors often monitor these filings to gauge executive sentiment and potential future performance.

Stakeholder Impact

• Shareholders may view the executive's stock and option acquisition as a positive sign.

Key Dates

Keywords

Form 4, Jaguar Health, Stock Options, Common Stock, Beneficial Ownership, Steven R. King, Reverse Stock Split